Dr. Karel specializes in drug information services and is involved in the formulary committee at Children’s Hospital of Philadelphia.
Pharmacy Practice (PGY 1) - Christiana Care Health System, Newark, DE
Drug Information Specialty (PGY 2) - Thomas Jefferson University Hospital, Philadelphia, PA
Board Certified Pharmacotherapy Specialist (BCPS)
PharmD – Jefferson College of Pharmacy, Thomas Jefferson University, Philadelphia, PA
Clinical Pharmacy Specialist in Drug Information
Karel LI, Delisle DR, Anagnostis EA, Wordell CJ. Implementation of a formulary management process. Am J Health Syst Pharm. 2017;74(16):1245-1252.
Umland EM, Karel L, Santoro N. Bazedoxifene and conjugated equine estrogen: A combination product for the management of vasomotor symptoms and osteoporosis prevention associated with menopause. Pharmacotherapy. 2016;36(5):548-561.
Karel LI, Handzel MC, Rosini JM. Laundry Detergent Pod Ingestion in 2 Pediatric Patients. J Emerg Nurs. 2015;41(1):80-82.
Bouazza B, Debba-Pavard M, Amrani Y, Isaacs L, O'Connell D, Ahamed S, Formella D, Tliba O. Basal p38 MAPK Regulates Unliganded Glucocorticoid Receptor function in Airway Smooth Muscle Cells. Am J Respir Cell Mol Biol. 2014. 50(2):301-315.
Karel L. The Basics of Biosimilars: Insights for healthcare providers. Platform presentation during the Nursing/Pharmacy/CRA Education Symposium at: ECOG-ACRIN Spring Group Meeting; 2017 May 4-6; Washington, DC.
Shah P, Karel L. On your P&T agenda: Integrating biosimilars into the formulary process and assessing interchangeability and extrapolation. Platform presentation during the Innovations in Drug Information session at: ASHP Midyear Clinical Meeting and Exhibition; 2016 Dec 4-8; Las Vegas, NV.
Karel L. A lean approach to formulary management. Platform presentation during the Innovations in Drug Information session at: ASHP Midyear Clinical Meeting and Exhibition; 2015 Dec 6-10; New Orleans, LA.
American Society of Health-System Pharmacists (ASHP)